EMEA (Europe, Middle East and Africa) Oral Solid Dosage Form Excipients Market Report 2017

October 2017 | 122 pages | ID: EB9606D3E8FPEN
QYResearch

Abstracts

In this report, the EMEA Oral Solid Dosage Form Excipients market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Oral Solid Dosage Form Excipients for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Oral Solid Dosage Form Excipients market competition by top manufacturers/players, with Oral Solid Dosage Form Excipients sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Abitec
• Ashland
• BASF
• Croda
• Dow
• Evonik
• Gattefosse
• Shin-Etsu
• Clariant
• Cytec
• Disruptive Materials
• FMC BioPolymer
• Freund
• Fuji Chemical Industry
• Indion
• Maple Biotech
• Merck Millipore
• Peter Cremer
• Purolite
• Roquette
• Seppic
• SPI Phrama
• Stepan
• Sumitomo Chemical
• Thermax
• Wacker Chemie

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

• Type I
• Type II

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Oral Solid Dosage Form Excipients for each application, including

• Oral Solid Dosage Form
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Oral Solid Dosage Form Excipients Market Report 2017

1 ORAL SOLID DOSAGE FORM EXCIPIENTS OVERVIEW

1.1 Product Overview and Scope of Oral Solid Dosage Form Excipients
1.2 Classification of Oral Solid Dosage Form Excipients
  1.2.1 EMEA Oral Solid Dosage Form Excipients Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Oral Solid Dosage Form Excipients Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3
  1.2.4
1.3 EMEA Oral Solid Dosage Form Excipients Market by Application/End Users
  1.3.1 EMEA Oral Solid Dosage Form Excipients Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Oral Solid Dosage Form
  1.3.3 Other
1.4 EMEA Oral Solid Dosage Form Excipients Market by Region
  1.4.1 EMEA Oral Solid Dosage Form Excipients Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Oral Solid Dosage Form Excipients (2012-2022)
  1.5.1 EMEA Oral Solid Dosage Form Excipients Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Oral Solid Dosage Form Excipients Revenue and Growth Rate (2012-2022)

2 EMEA ORAL SOLID DOSAGE FORM EXCIPIENTS COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Oral Solid Dosage Form Excipients Market Competition by Players/Manufacturers
  2.1.1 EMEA Oral Solid Dosage Form Excipients Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Oral Solid Dosage Form Excipients Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Oral Solid Dosage Form Excipients Sale Price by Players (2012-2017)
2.2 EMEA Oral Solid Dosage Form Excipients (Volume and Value) by Type/Product Category
  2.2.1 EMEA Oral Solid Dosage Form Excipients Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Oral Solid Dosage Form Excipients Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Oral Solid Dosage Form Excipients Sale Price by Type (2012-2017)
2.3 EMEA Oral Solid Dosage Form Excipients (Volume) by Application
2.4 EMEA Oral Solid Dosage Form Excipients (Volume and Value) by Region
  2.4.1 EMEA Oral Solid Dosage Form Excipients Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Oral Solid Dosage Form Excipients Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Oral Solid Dosage Form Excipients Sales Price by Region (2012-2017)

3 EUROPE ORAL SOLID DOSAGE FORM EXCIPIENTS (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Oral Solid Dosage Form Excipients Sales and Value (2012-2017)
  3.1.1 Europe Oral Solid Dosage Form Excipients Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Oral Solid Dosage Form Excipients Revenue and Growth Rate (2012-2017)
3.2 Europe Oral Solid Dosage Form Excipients Sales and Market Share by Type
3.3 Europe Oral Solid Dosage Form Excipients Sales and Market Share by Application
3.4 Europe Oral Solid Dosage Form Excipients Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Oral Solid Dosage Form Excipients Sales Volume by Countries (2012-2017)
  3.4.2 Europe Oral Solid Dosage Form Excipients Revenue by Countries (2012-2017)
  3.4.3 Germany Oral Solid Dosage Form Excipients Sales and Growth Rate (2012-2017)
  3.4.4 France Oral Solid Dosage Form Excipients Sales and Growth Rate (2012-2017)
  3.4.5 UK Oral Solid Dosage Form Excipients Sales and Growth Rate (2012-2017)
  3.4.6 Russia Oral Solid Dosage Form Excipients Sales and Growth Rate (2012-2017)
  3.4.7 Italy Oral Solid Dosage Form Excipients Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Oral Solid Dosage Form Excipients Sales and Growth Rate (2012-2017)

4 MIDDLE EAST ORAL SOLID DOSAGE FORM EXCIPIENTS (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Oral Solid Dosage Form Excipients Sales and Value (2012-2017)
  4.1.1 Middle East Oral Solid Dosage Form Excipients Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Oral Solid Dosage Form Excipients Revenue and Growth Rate (2012-2017)
4.2 Middle East Oral Solid Dosage Form Excipients Sales and Market Share by Type
4.3 Middle East Oral Solid Dosage Form Excipients Sales and Market Share by Application
4.4 Middle East Oral Solid Dosage Form Excipients Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Oral Solid Dosage Form Excipients Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Oral Solid Dosage Form Excipients Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Oral Solid Dosage Form Excipients Sales and Growth Rate (2012-2017)
  4.4.4 Israel Oral Solid Dosage Form Excipients Sales and Growth Rate (2012-2017)
  4.4.5 UAE Oral Solid Dosage Form Excipients Sales and Growth Rate (2012-2017)
  4.4.6 Iran Oral Solid Dosage Form Excipients Sales and Growth Rate (2012-2017)

5 AFRICA ORAL SOLID DOSAGE FORM EXCIPIENTS (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Oral Solid Dosage Form Excipients Sales and Value (2012-2017)
  5.1.1 Africa Oral Solid Dosage Form Excipients Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Oral Solid Dosage Form Excipients Revenue and Growth Rate (2012-2017)
5.2 Africa Oral Solid Dosage Form Excipients Sales and Market Share by Type
5.3 Africa Oral Solid Dosage Form Excipients Sales and Market Share by Application
5.4 Africa Oral Solid Dosage Form Excipients Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Oral Solid Dosage Form Excipients Sales Volume by Countries (2012-2017)
  5.4.2 Africa Oral Solid Dosage Form Excipients Revenue by Countries (2012-2017)
  5.4.3 South Africa Oral Solid Dosage Form Excipients Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Oral Solid Dosage Form Excipients Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Oral Solid Dosage Form Excipients Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Oral Solid Dosage Form Excipients Sales and Growth Rate (2012-2017)

6 EMEA ORAL SOLID DOSAGE FORM EXCIPIENTS MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Abitec
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Oral Solid Dosage Form Excipients Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Abitec Oral Solid Dosage Form Excipients Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Ashland
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Oral Solid Dosage Form Excipients Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Ashland Oral Solid Dosage Form Excipients Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 BASF
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Oral Solid Dosage Form Excipients Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 BASF Oral Solid Dosage Form Excipients Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Croda
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Oral Solid Dosage Form Excipients Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Croda Oral Solid Dosage Form Excipients Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Dow
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Oral Solid Dosage Form Excipients Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Dow Oral Solid Dosage Form Excipients Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Evonik
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Oral Solid Dosage Form Excipients Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Evonik Oral Solid Dosage Form Excipients Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Gattefosse
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Oral Solid Dosage Form Excipients Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Gattefosse Oral Solid Dosage Form Excipients Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Shin-Etsu
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Oral Solid Dosage Form Excipients Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Shin-Etsu Oral Solid Dosage Form Excipients Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Clariant
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Oral Solid Dosage Form Excipients Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Clariant Oral Solid Dosage Form Excipients Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Cytec
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Oral Solid Dosage Form Excipients Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Cytec Oral Solid Dosage Form Excipients Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Disruptive Materials
6.12 FMC BioPolymer
6.13 Freund
6.14 Fuji Chemical Industry
6.15 Indion
6.16 Maple Biotech
6.17 Merck Millipore
6.18 Peter Cremer
6.19 Purolite
6.20 Roquette
6.21 Seppic
6.22 SPI Phrama
6.23 Stepan
6.24 Sumitomo Chemical
6.25 Thermax
6.26 Wacker Chemie

7 ORAL SOLID DOSAGE FORM EXCIPIENTS MANUFACTURING COST ANALYSIS

7.1 Oral Solid Dosage Form Excipients Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Oral Solid Dosage Form Excipients

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Oral Solid Dosage Form Excipients Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Oral Solid Dosage Form Excipients Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA ORAL SOLID DOSAGE FORM EXCIPIENTS MARKET FORECAST (2017-2022)

11.1 EMEA Oral Solid Dosage Form Excipients Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Oral Solid Dosage Form Excipients Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Oral Solid Dosage Form Excipients Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Oral Solid Dosage Form Excipients Price and Trend Forecast (2017-2022)
11.2 EMEA Oral Solid Dosage Form Excipients Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Oral Solid Dosage Form Excipients Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Oral Solid Dosage Form Excipients Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Oral Solid Dosage Form Excipients Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Oral Solid Dosage Form Excipients Sales Forecast by Type (2017-2022)
11.7 EMEA Oral Solid Dosage Form Excipients Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Oral Solid Dosage Form Excipients
Figure EMEA Oral Solid Dosage Form Excipients Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Oral Solid Dosage Form Excipients Sales Volume Market Share by Type (Product Category) in 2016
Figure Type I Product Picture
Figure Type II Product Picture
Figure EMEA Oral Solid Dosage Form Excipients Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Oral Solid Dosage Form Excipients by Application in 2016
Figure Oral Solid Dosage Form Examples
Table Key Downstream Customer in Oral Solid Dosage Form
Figure Other Examples
Table Key Downstream Customer in Other
Figure EMEA Oral Solid Dosage Form Excipients Market Size (Million USD) by Region (2012-2022)
Figure Europe Oral Solid Dosage Form Excipients Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Oral Solid Dosage Form Excipients Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Oral Solid Dosage Form Excipients Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Oral Solid Dosage Form Excipients Revenue (Million USD) Status and Forecast by Countries
Figure Africa Oral Solid Dosage Form Excipients Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Oral Solid Dosage Form Excipients Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Oral Solid Dosage Form Excipients Sales Volume and Growth Rate (2012-2022)
Figure EMEA Oral Solid Dosage Form Excipients Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Oral Solid Dosage Form Excipients Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Oral Solid Dosage Form Excipients Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Oral Solid Dosage Form Excipients Sales Share by Players (2012-2017)
Figure 2016 Oral Solid Dosage Form Excipients Sales Share by Players
Figure 2017 Oral Solid Dosage Form Excipients Sales Share by Players
Figure EMEA Oral Solid Dosage Form Excipients Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Oral Solid Dosage Form Excipients Revenue (Million USD) by Players (2012-2017)
Table EMEA Oral Solid Dosage Form Excipients Revenue Share by Players (2012-2017)
Table 2016 EMEA Oral Solid Dosage Form Excipients Revenue Share by Players
Table 2017 EMEA Oral Solid Dosage Form Excipients Revenue Share by Players
Table EMEA Oral Solid Dosage Form Excipients Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Oral Solid Dosage Form Excipients Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Oral Solid Dosage Form Excipients Sales Share by Type (2012-2017)
Figure Sales Market Share of Oral Solid Dosage Form Excipients by Type (2012-2017)
Figure EMEA Oral Solid Dosage Form Excipients Sales Market Share by Type (2012-2017)
Table EMEA Oral Solid Dosage Form Excipients Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Oral Solid Dosage Form Excipients Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Oral Solid Dosage Form Excipients by Type in 2016
Table EMEA Oral Solid Dosage Form Excipients Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Oral Solid Dosage Form Excipients Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Oral Solid Dosage Form Excipients Sales Share by Application (2012-2017)
Figure Sales Market Share of Oral Solid Dosage Form Excipients by Application (2012-2017)
Figure EMEA Oral Solid Dosage Form Excipients Sales Market Share by Application in 2016
Table EMEA Oral Solid Dosage Form Excipients Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Oral Solid Dosage Form Excipients Sales Share by Region (2012-2017)
Figure Sales Market Share of Oral Solid Dosage Form Excipients by Region (2012-2017)
Figure EMEA Oral Solid Dosage Form Excipients Sales Market Share in 2016
Table EMEA Oral Solid Dosage Form Excipients Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Oral Solid Dosage Form Excipients Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Oral Solid Dosage Form Excipients by Region (2012-2017)
Figure EMEA Oral Solid Dosage Form Excipients Revenue Market Share Regions in 2016
Table EMEA Oral Solid Dosage Form Excipients Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Oral Solid Dosage Form Excipients Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Oral Solid Dosage Form Excipients Revenue and Growth Rate (2012-2017)
Table Europe Oral Solid Dosage Form Excipients Sales (K Units) by Type (2012-2017)
Table Europe Oral Solid Dosage Form Excipients Market Share by Type (2012-2017)
Figure Europe Oral Solid Dosage Form Excipients Market Share by Type in 2016
Table Europe Oral Solid Dosage Form Excipients Sales (K Units) by Application (2012-2017)
Table Europe Oral Solid Dosage Form Excipients Market Share by Application (2012-2017)
Figure Europe Oral Solid Dosage Form Excipients Market Share by Application in 2016
Table Europe Oral Solid Dosage Form Excipients Sales (K Units) by Countries (2012-2017)
Table Europe Oral Solid Dosage Form Excipients Sales Market Share by Countries (2012-2017)
Figure Europe Oral Solid Dosage Form Excipients Sales Market Share by Countries (2012-2017)
Figure Europe Oral Solid Dosage Form Excipients Sales Market Share by Countries in 2016
Table Europe Oral Solid Dosage Form Excipients Revenue (Million USD) by Countries (2012-2017)
Table Europe Oral Solid Dosage Form Excipients Revenue Market Share by Countries (2012-2017)
Figure Europe Oral Solid Dosage Form Excipients Revenue Market Share by Countries (2012-2017)
Figure Europe Oral Solid Dosage Form Excipients Revenue Market Share by Countries in 2016
Figure Germany Oral Solid Dosage Form Excipients Sales (K Units) and Growth Rate (2012-2017)
Figure France Oral Solid Dosage Form Excipients Sales (K Units) and Growth Rate (2012-2017)
Figure UK Oral Solid Dosage Form Excipients Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Oral Solid Dosage Form Excipients Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Oral Solid Dosage Form Excipients Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Oral Solid Dosage Form Excipients Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Oral Solid Dosage Form Excipients Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Oral Solid Dosage Form Excipients Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Oral Solid Dosage Form Excipients Sales (K Units) by Type (2012-2017)
Table Middle East Oral Solid Dosage Form Excipients Market Share by Type (2012-2017)
Figure Middle East Oral Solid Dosage Form Excipients Market Share by Type (2012-2017)
Table Middle East Oral Solid Dosage Form Excipients Sales (K Units) by Applications (2012-2017)
Table Middle East Oral Solid Dosage Form Excipients Market Share by Applications (2012-2017)
Figure Middle East Oral Solid Dosage Form Excipients Sales Market Share by Application in 2016
Table Middle East Oral Solid Dosage Form Excipients Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Oral Solid Dosage Form Excipients Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Oral Solid Dosage Form Excipients Sales Volume Market Share by Countries in 2016
Table Middle East Oral Solid Dosage Form Excipients Revenue (Million USD) by Countries (2012-2017)
Table Middle East Oral Solid Dosage Form Excipients Revenue Market Share by Countries (2012-2017)
Figure Middle East Oral Solid Dosage Form Excipients Revenue Market Share by Countries (2012-2017)
Figure Middle East Oral Solid Dosage Form Excipients Revenue Market Share by Countries in 2016
Figure Saudi Arabia Oral Solid Dosage Form Excipients Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Oral Solid Dosage Form Excipients Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Oral Solid Dosage Form Excipients Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Oral Solid Dosage Form Excipients Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Oral Solid Dosage Form Excipients Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Oral Solid Dosage Form Excipients Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Oral Solid Dosage Form Excipients Sales (K Units) by Type (2012-2017)
Table Africa Oral Solid Dosage Form Excipients Sales Market Share by Type (2012-2017)
Figure Africa Oral Solid Dosage Form Excipients Sales Market Share by Type (2012-2017)
Figure Africa Oral Solid Dosage Form Excipients Sales Market Share by Type in 2016
Table Africa Oral Solid Dosage Form Excipients Sales (K Units) by Application (2012-2017)
Table Africa Oral Solid Dosage Form Excipients Sales Market Share by Application (2012-2017)
Figure Africa Oral Solid Dosage Form Excipients Sales Market Share by Application (2012-2017)
Table Africa Oral Solid Dosage Form Excipients Sales Volume (K Units) by Countries (2012-2017)
Table Africa Oral Solid Dosage Form Excipients Sales Market Share by Countries (2012-2017)
Figure Africa Oral Solid Dosage Form Excipients Sales Market Share by Countries (2012-2017)
Figure Africa Oral Solid Dosage Form Excipients Sales Market Share by Countries in 2016
Table Africa Oral Solid Dosage Form Excipients Revenue (Million USD) by Countries (2012-2017)
Table Africa Oral Solid Dosage Form Excipients Revenue Market Share by Countries (2012-2017)
Figure Africa Oral Solid Dosage Form Excipients Revenue Market Share by Countries (2012-2017)
Figure Africa Oral Solid Dosage Form Excipients Revenue Market Share by Countries in 2016
Figure South Africa Oral Solid Dosage Form Excipients Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Oral Solid Dosage Form Excipients Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Oral Solid Dosage Form Excipients Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Oral Solid Dosage Form Excipients Sales (K Units) and Growth Rate (2012-2017)
Table Abitec Oral Solid Dosage Form Excipients Basic Information List
Table Abitec Oral Solid Dosage Form Excipients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Abitec Oral Solid Dosage Form Excipients Sales (K Units) and Growth Rate (2012-2017)
Figure Abitec Oral Solid Dosage Form Excipients Sales Market Share in EMEA (2012-2017)
Figure Abitec Oral Solid Dosage Form Excipients Revenue Market Share in EMEA (2012-2017)
Table Ashland Oral Solid Dosage Form Excipients Basic Information List
Table Ashland Oral Solid Dosage Form Excipients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Ashland Oral Solid Dosage Form Excipients Sales (K Units) and Growth Rate (2012-2017)
Figure Ashland Oral Solid Dosage Form Excipients Sales Market Share in EMEA (2012-2017)
Figure Ashland Oral Solid Dosage Form Excipients Revenue Market Share in EMEA (2012-2017)
Table BASF Oral Solid Dosage Form Excipients Basic Information List
Table BASF Oral Solid Dosage Form Excipients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure BASF Oral Solid Dosage Form Excipients Sales (K Units) and Growth Rate (2012-2017)
Figure BASF Oral Solid Dosage Form Excipients Sales Market Share in EMEA (2012-2017)
Figure BASF Oral Solid Dosage Form Excipients Revenue Market Share in EMEA (2012-2017)
Table Croda Oral Solid Dosage Form Excipients Basic Information List
Table Croda Oral Solid Dosage Form Excipients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Croda Oral Solid Dosage Form Excipients Sales (K Units) and Growth Rate (2012-2017)
Figure Croda Oral Solid Dosage Form Excipients Sales Market Share in EMEA (2012-2017)
Figure Croda Oral Solid Dosage Form Excipients Revenue Market Share in EMEA (2012-2017)
Table Dow Oral Solid Dosage Form Excipients Basic Information List
Table Dow Oral Solid Dosage Form Excipients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Dow Oral Solid Dosage Form Excipients Sales (K Units) and Growth Rate (2012-2017)
Figure Dow Oral Solid Dosage Form Excipients Sales Market Share in EMEA (2012-2017)
Figure Dow Oral Solid Dosage Form Excipients Revenue Market Share in EMEA (2012-2017)
Table Evonik Oral Solid Dosage Form Excipients Basic Information List
Table Evonik Oral Solid Dosage Form Excipients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Evonik Oral Solid Dosage Form Excipients Sales (K Units) and Growth Rate (2012-2017)
Figure Evonik Oral Solid Dosage Form Excipients Sales Market Share in EMEA (2012-2017)
Figure Evonik Oral Solid Dosage Form Excipients Revenue Market Share in EMEA (2012-2017)
Table Gattefosse Oral Solid Dosage Form Excipients Basic Information List
Table Gattefosse Oral Solid Dosage Form Excipients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Gattefosse Oral Solid Dosage Form Excipients Sales (K Units) and Growth Rate (2012-2017)
Figure Gattefosse Oral Solid Dosage Form Excipients Sales Market Share in EMEA (2012-2017)
Figure Gattefosse Oral Solid Dosage Form Excipients Revenue Market Share in EMEA (2012-2017)
Table Shin-Etsu Oral Solid Dosage Form Excipients Basic Information List
Table Shin-Etsu Oral Solid Dosage Form Excipients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Shin-Etsu Oral Solid Dosage Form Excipients Sales (K Units) and Growth Rate (2012-2017)
Figure Shin-Etsu Oral Solid Dosage Form Excipients Sales Market Share in EMEA (2012-2017)
Figure Shin-Etsu Oral Solid Dosage Form Excipients Revenue Market Share in EMEA (2012-2017)
Table Clariant Oral Solid Dosage Form Excipients Basic Information List
Table Clariant Oral Solid Dosage Form Excipients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Clariant Oral Solid Dosage Form Excipients Sales (K Units) and Growth Rate (2012-2017)
Figure Clariant Oral Solid Dosage Form Excipients Sales Market Share in EMEA (2012-2017)
Figure Clariant Oral Solid Dosage Form Excipients Revenue Market Share in EMEA (2012-2017)
Table Cytec Oral Solid Dosage Form Excipients Basic Information List
Table Cytec Oral Solid Dosage Form Excipients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Cytec Oral Solid Dosage Form Excipients Sales (K Units) and Growth Rate (2012-2017)
Figure Cytec Oral Solid Dosage Form Excipients Sales Market Share in EMEA (2012-2017)
Figure Cytec Oral Solid Dosage Form Excipients Revenue Market Share in EMEA (2012-2017)
Table Disruptive Materials Oral Solid Dosage Form Excipients Basic Information List
Table FMC BioPolymer Oral Solid Dosage Form Excipients Basic Information List
Table Freund Oral Solid Dosage Form Excipients Basic Information List
Table Fuji Chemical Industry Oral Solid Dosage Form Excipients Basic Information List
Table Indion Oral Solid Dosage Form Excipients Basic Information List
Table Maple Biotech Oral Solid Dosage Form Excipients Basic Information List
Table Merck Millipore Oral Solid Dosage Form Excipients Basic Information List
Table Peter Cremer Oral Solid Dosage Form Excipients Basic Information List
Table Purolite Oral Solid Dosage Form Excipients Basic Information List
Table Roquette Oral Solid Dosage Form Excipients Basic Information List
Table Seppic Oral Solid Dosage Form Excipients Basic Information List
Table SPI Phrama Oral Solid Dosage Form Excipients Basic Information List
Table Stepan Oral Solid Dosage Form Excipients Basic Information List
Table Sumitomo Chemical Oral Solid Dosage Form Excipients Basic Information List
Table Thermax Oral Solid Dosage Form Excipients Basic Information List
Table Wacker Chemie Oral Solid Dosage Form Excipients Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oral Solid Dosage Form Excipients
Figure Manufacturing Process Analysis of Oral Solid Dosage Form Excipients
Figure Oral Solid Dosage Form Excipients Industrial Chain Analysis
Table Raw Materials Sources of Oral Solid Dosage Form Excipients Major Manufacturers in 2016
Table Major Buyers of Oral Solid Dosage Form Excipients
Table Distributors/Traders List
Figure EMEA Oral Solid Dosage Form Excipients Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Oral Solid Dosage Form Excipients Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Oral Solid Dosage Form Excipients Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Oral Solid Dosage Form Excipients Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Oral Solid Dosage Form Excipients Sales Market Share Forecast by Region (2017-2022)
Table EMEA Oral Solid Dosage Form Excipients Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Oral Solid Dosage Form Excipients Revenue Market Share Forecast by Region (2017-2022)
Table Europe Oral Solid Dosage Form Excipients Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Oral Solid Dosage Form Excipients Sales Market Share Forecast by Countries (2017-2022)
Table Europe Oral Solid Dosage Form Excipients Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Oral Solid Dosage Form Excipients Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Oral Solid Dosage Form Excipients Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Oral Solid Dosage Form Excipients Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Oral Solid Dosage Form Excipients Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Oral Solid Dosage Form Excipients Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Oral Solid Dosage Form Excipients Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Oral Solid Dosage Form Excipients Sales Market Share Forecast by Countries (2017-2022)
Table Africa Oral Solid Dosage Form Excipients Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Oral Solid Dosage Form Excipients Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Oral Solid Dosage Form Excipients Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Oral Solid Dosage Form Excipients Sales Market Share Forecast by Type (2017-2022)
Table EMEA Oral Solid Dosage Form Excipients Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Oral Solid Dosage Form Excipients Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources